Sustained local delivery of heparin to the rabbit arterial wall with an electroporation catheter

Catheterization and Cardiovascular Diagnosis

Volumn 45, Issue 3, 1998, Pages 337-345

  Dev, Nagendu B ^a,b   Preminger, Tamar J ^a   Hofmann, Günter A ^b   Dev, Sukhendu B ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b Inovio Biomedical Corporation   (United States)

Author keywords

Electroporation; Heparin; Local drug delivery; Restenosis

Indexed keywords

HEPARIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING TIME; CAROTID ARTERY; DRUG DELIVERY SYSTEM; DRUG TISSUE LEVEL; ELECTROPORATION; FLUORESCENCE; HEART CATHETERIZATION; HEMODYNAMIC PARAMETERS; HISTOLOGY; INTRAARTERIAL DRUG ADMINISTRATION; NONHUMAN; RABBIT; RESTENOSIS; SAFETY;

ANIMALS; ANTICOAGULANTS; BLOOD PRESSURE; CAROTID ARTERY, COMMON; CAROTID STENOSIS; CATHETERIZATION, PERIPHERAL; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; ELECTROPORATION; FEMALE; HEPARIN; INJECTIONS, INTRA-ARTERIAL; MALE; RABBITS; SAFETY; TREATMENT OUTCOME;

EID: 0031758146     PISSN: 00986569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0304(199811)45:3<337::AID-CCD28>3.0.CO;2-J     Document Type: Article

References (30)

1. Hofling B, Gonschior P, Mack B, Gerheuser F, Bauriedel G, Nerlich A, Welsh U, Simpson JB: Current status of directional coronary atherectomy in interventional cardiology. Z Kardiol [Suppl] 80:25-34, 1991.
2. Margolis JR, Morgensen L, Mehta S, Chen C, Krauthamer D: Diffuse embolization following percutaneous transluminal coronary angioplasty of occluded vein grafts: The blush phenomenon. Clin Cardiol 14:489-493, 1991.
3. Serruys PW, Strauss BH, Van Beusekom HM, Van der Giessen WJ: Stenting of coronary arteries: Has a modern Pandora's box been opened? J Am Coll Cardiol [Suppl] 17:143-154, 1991.
4. Warth DC, Leon MB, O'Neill W, Zacca N, Polissar NL, Buchbinder M: Rotational Atherectomy Multicenter Registry: Acute results, complications and 6-month angiographic follow-up in 709 patients. J Am Coll Cardiol 24:641-648, 1994.
5. Leclercq F, Grolleau R: Mechanism of restenosis after coronary angioplasty. Arch Mal Coeur 89:359-365, 1996.
6. Hapala I: Breaking the barrier methods for reversible permeabilization of cellular membrane. Crit Rev Biotechnol 17:105-122, 1997.
7. Nishi T, Yoshizato K, Yamashiro S, Takeshima H, Sato K, Hamada K, Kitamura I, Yoshimura T, Saya H, Kuratsu JI, Ushio Y: High efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation. Cancer Res 56:1050-1055, 1996.
8. Prausnitz MR: The effects of electric current applied to skin: A review for transdermal drug delivery. Adv Drug Deliv 18:395-425, 1996.
9. Zhang L, Li L, Hofmann GA, Hoffman RM: Depth-targeted efficient gene delivery and expression in the skin by pulsed electric fields: An approach to gene therapy of skin aging and other diseases. Biochem Biophys Res Commun 220:633-636, 1996.
10. Sixou S, Teissie J: Specific electropermeabilization of leucocytes in a blood sample and application to large volumes of cells. Biochim Biophys Acta 1028:154-160, 1990.
11. Clowes AW, Clowes MM: Kinetics of cellular proliferation after arterial injury. IV. Heparin inhibits rat smooth muscle mitogenesis and migration. Circ Res 58:839-845, 1986.
12. Volpi N, Petrini M, Conte M, Valentini P, Venturelli T, Bolognani L, Ronca G: Effects of glycosaminoglycans on U-937 leukemia cell proliferation and differentiation: Structure-function relationship. Exp Cell Res 215:119-130, 1994.
13. Araki H, Muramato J, Nishi K, Jougasaki M, Inoue M: Heparin adheres to the damaged arterial wall and inhibits its thrombogenicity. Circ Res 71:577-584, 1992.
14. Black SC, Gralinski MR, Friedrichs GS, Kilgore KS, Driscoll EM, Lucchesi BR: Cardioprotective effects of heparin or N-acetylheparin in an in vivo model of myocardial ischaemia and reperfusion. Cardiovasc Res 29:629-636, 1995.
15. Edelman ER, Karnovsky MJ: Contrasting effect of the intermittent and continuous administration of heparin in experimental restenosis. Circulation 89:770-776, 1994.
16. Hofmann GA: Cells in electric fields: Physical and practical electronic aspects of electro cell fusion and electroporation. In Neumann E, Sowers A, Jordan C (eds): "Electroporation and Electrofusion in Cell Biology." New York: Plenum Press, 1989, pp 389-407.
17. Mize RR: Quantitative image analysis for immunocytochemistry and in situ hybridization. J Neurosci Methods 54:219-237, 1994.
18. Shaw SL, Salmon SD, Quatrano RS: Digital photography for the light microscope: Results with a gated, video-rate CCD camera and NIH-image software. Biotechniques 19:946-955, 1995.
19. Yumura S, Matsuzuki R, Kitanishi-Yumura T: Introduction of macromolecules into living Dictyostelium cells by electroporation. Cell Struct Funct 20:185-190, 1995.
20. Glogauer M, Lee W, McCulloch CA: Induced endocytosis in human fibroblasts by electrical Fields. Exp Cell Res 208:232-240, 1993.
21. Kakuta T, Currier JW, Haudenschild CC, Ryan TJ, Faxon TD: Differences in compensatory vessel enlargement, not intimal formation, account for restenosis after angioplasty in the hypercholesterolemic rabbit model. Circulation 89:2809-2815, 1994.
22. Fischell TA: Coronary artery spasm after percutaneous transluminal coronary angioplasty: Pathophysiology and clinical consequences. Cathet Cardiovasc Diagn 19:1-3, 1990.
23. Fischman DL: The platelet, the patient and periprocedural infarction during percutaneous transluminal coronary angioplasty. JAMA 278:518-519, 1997.
24. Hadoke PW, Wadsworth RM, Wainright CL: Characterization of the responses of isolated rings of rabbit left carotid artery. A potential protocol for the assessment of pathologically induced functional changes. J Pharmacol Toxicol Methods 29:195-202, 1993.
25. Giordano FJ, Dev SB, Adams M, Hofmann GA, Brown DL: In vivo gene delivery to the rabbit carotid by electroporation. Abstract 780-4, American College of Cardiology meeting, Orlando, FL, March 1996.
26. Wolinsky H, Thung SN: Use of a perforated catheter to deliver concentrated heparin into the wall of the normal canine artery. J Am Coll Cardiol 15:475-481, 1990.
27. Gimple LW, Gertz SD, Haber HL, Ragosta M, Powers ER, Roberts EC, Sarembock IJ: Effect of chronic subcutaneous or intramural administration of heparin on femoral artery restenosis after balloon angioplasty in hypercholesterolemic rabbits. Circulation 86:1536-1546, 1992.
28. Fernandez-Ortiz A, Meyer BJ, Mailhac A, Falk E, Badimon L, Fallon JT, Fuster V, Chesebro JH, Badimon JJ: A new approach for local intravascular drug delivery. Circulation 89:1518-1522, 1994.
29. Cui J, Robinson KA, Brown JE, Chronos N, Cipolla GD, Dev SB, Hofmann GA, Crawford N, King SB: Local drug delivery to pig carotid arteries by direct vessel wall electroporation using a novel catheter. Abstract 749-4, American College of Cardiology meeting, Anaheim, CA, March 1997.
30. Fareed J, Walenga JM, Leya F, Bacher P, Hoppensteadt D, Messmore H, Pifarre R: Some objective considerations for the use of heparins and recombinant hirudin in percutaneous transluminal coronary angioplasty. Semin Thromb Hemost 17:455-470, 1991.